These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 28738540)

  • 1. Regulatory players of DNA damage repair mechanisms: Role in Cancer Chemoresistance.
    Sakthivel KM; Hariharan S
    Biomed Pharmacother; 2017 Sep; 93():1238-1245. PubMed ID: 28738540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA repair pathways and cisplatin resistance: an intimate relationship.
    Rocha CRR; Silva MM; Quinet A; Cabral-Neto JB; Menck CFM
    Clinics (Sao Paulo); 2018 Sep; 73(suppl 1):e478s. PubMed ID: 30208165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk between DNA repair and cancer stem cell (CSC) associated intracellular pathways.
    Skvortsov S; Debbage P; Lukas P; Skvortsova I
    Semin Cancer Biol; 2015 Apr; 31():36-42. PubMed ID: 24954010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in DNA mismatch repair genes: implications for DNA damage signaling and drug sensitivity (review).
    Fedier A; Fink D
    Int J Oncol; 2004 Apr; 24(4):1039-47. PubMed ID: 15010846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of tolerance to DNA damaging therapeutic drugs.
    Karran P
    Carcinogenesis; 2001 Dec; 22(12):1931-7. PubMed ID: 11751422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin regulates the MAPK kinase pathway to induce increased expression of DNA repair gene ERCC1 and increase melanoma chemoresistance.
    Li W; Melton DW
    Oncogene; 2012 May; 31(19):2412-22. PubMed ID: 21996734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA damage and repair in translational oncology: an overview.
    Reed E
    Clin Cancer Res; 2010 Sep; 16(18):4511-6. PubMed ID: 20823144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance.
    Bouwman P; Jonkers J
    Nat Rev Cancer; 2012 Sep; 12(9):587-98. PubMed ID: 22918414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple roles of the ERCC1-XPF endonuclease in DNA repair and resistance to anticancer drugs.
    Kirschner K; Melton DW
    Anticancer Res; 2010 Sep; 30(9):3223-32. PubMed ID: 20944091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunities for translation: targeting DNA repair pathways in pancreatic cancer.
    Maginn EN; de Sousa CH; Wasan HS; Stronach EA
    Biochim Biophys Acta; 2014 Aug; 1846(1):45-54. PubMed ID: 24727386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of DNA repair pathways in cisplatin resistant lung cancer.
    O'Grady S; Finn SP; Cuffe S; Richard DJ; O'Byrne KJ; Barr MP
    Cancer Treat Rev; 2014 Dec; 40(10):1161-70. PubMed ID: 25458603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Stem Cells and Chemoresistance in Glioblastoma Multiform: A Review Article.
    Safari M; Khoshnevisan A
    J Stem Cells; 2015; 10(4):271-85. PubMed ID: 27144829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The DNA damage response: implications for tumor responses to radiation and chemotherapy.
    Goldstein M; Kastan MB
    Annu Rev Med; 2015; 66():129-43. PubMed ID: 25423595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting homologous recombination repair defects in cancer.
    Evers B; Helleday T; Jonkers J
    Trends Pharmacol Sci; 2010 Aug; 31(8):372-80. PubMed ID: 20598756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression.
    Turner KM; Sun Y; Ji P; Granberg KJ; Bernard B; Hu L; Cogdell DE; Zhou X; Yli-Harja O; Nykter M; Shmulevich I; Yung WK; Fuller GN; Zhang W
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3421-6. PubMed ID: 25737557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Mechanisms of Chemoresistance in Oral Cancer.
    Wang C; Liu XQ; Hou JS; Wang JN; Huang HZ
    Chin J Dent Res; 2016 Mar; 19(1):25-33. PubMed ID: 26981604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA damage in cancer therapeutics: a boon or a curse?
    Khanna A
    Cancer Res; 2015 Jun; 75(11):2133-8. PubMed ID: 25931285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An unconventional role of BMP-Smad1 signaling in DNA damage response: a mechanism for tumor suppression.
    Liu H; Bao D; Xia X; Chau JF; Li B
    J Cell Biochem; 2014 Mar; 115(3):450-6. PubMed ID: 24142423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divide and conquer: nucleotide excision repair battles cancer and ageing.
    Mitchell JR; Hoeijmakers JH; Niedernhofer LJ
    Curr Opin Cell Biol; 2003 Apr; 15(2):232-40. PubMed ID: 12648680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular pathways: targeting the dependence of mutant RAS cancers on the DNA damage response.
    Grabocka E; Commisso C; Bar-Sagi D
    Clin Cancer Res; 2015 Mar; 21(6):1243-7. PubMed ID: 25424849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.